Liana Marino
Family Medicine · Riverside, CANPI 1710948450
Payments from drug & device makers
Across 255 payments — averaging $17.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$833
- Boehringer Ingelheim$665
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$475
- AstraZeneca$300
- AbbVie$264
- Lilly USA, LLC$254
- plus $2K from 31 others
What the payments were for
- Food & beverage$4,428100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 66 | $833 |
| Boehringer Ingelheim | 28 | $665 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 30 | $475 |
| AstraZeneca | 15 | $300 |
| AbbVie | 19 | $264 |
| Lilly USA, LLC | 11 | $254 |
| Abbott | 7 | $165 |
| Amarin Pharma, Inc. | 14 | $147 |
| Astellas Pharma US Inc | 5 | $121 |
| GSK | 4 | $108 |
| Novartis | 5 | $92 |
| Vyera Pharmaceuticals, LLC | 5 | $91 |
| Bayer | 4 | $90 |
| Pfizer | 4 | $81 |
| Corcept Therapeutics | 4 | $81 |
| Amgen | 3 | $72 |
| Dexcom, Inc. | 3 | $66 |
| Merck | 3 | $60 |
| Xeris Pharmaceuticals, Inc. | 3 | $54 |
| E.r. Squibb & Sons, L.L.C. | 3 | $40 |
| Exact Sciences | 2 | $35 |
| Johnson & Johnson | 2 | $33 |
| Ardelyx, Inc. | 1 | $32 |
| Aimmune Therapeutics, Inc. | 1 | $27 |
| Mannkind Corporation | 1 | $24 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Eisai Inc. | 1 | $20 |
| Alfasigma USA, Inc. | 1 | $19 |
| Bausch Health US, LLC | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Optos, Inc. | 1 | $18 |
| Tactile Systems Technology Inc | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $14 |
How this compares
$4,428 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 80 | $98,158 |
| LinzessLinaclotide | 51 | $57,725 |
| JanuviaSitagliptin Phosphate | 38 | $48,908 |
| EliquisApixaban | 44 | $43,157 |
| OzempicSemaglutide | 32 | $37,574 |
| RybelsusSemaglutide | 19 | $33,199 |
| JanumetSitagliptin Phos/Metformin Hcl | 25 | $25,116 |
| EntrestoSacubitril/Valsartan | 19 | $23,088 |
| TrulicityDulaglutide | 16 | $18,088 |
| TradjentaLinagliptin | 11 | $13,836 |
| FarxigaDapagliflozin Propanediol | 22 | $13,686 |
| Icosapent Ethyl | 19 | $12,479 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 58 | $8,033 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 16 | $5,789 |
| Atorvastatin Calcium | 307 | $5,712 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $665 | $111,99391 claims |
| MerckJanuvia, Janumet | $60 | $74,02463 claims |
| Novo NordiskOzempic, Rybelsus | $833 | $70,77351 claims |
| AbbVieLinzess | $264 | $57,72551 claims |
| PfizerEliquis | $81 | $43,15744 claims |
| NovartisEntresto | $92 | $23,08819 claims |
| Lilly USA, LLCTrulicity | $254 | $18,08816 claims |
| AstraZenecaFarxiga | $300 | $13,68622 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,533 family medicine providers in California.
Other family medicine in Riverside
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
- Apinya VutikullirdCypress$14.3M
- Hanid AudishSpring Valley$13.6M
- Augusto FocilOxnard$12.6M
- Jack VuLong Beach$10.1M
- Suzanne FussellOxnard$8.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.